We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Findings published in the NEJM indicate that Pfizer and BioNTech's widely used COVID-19 vaccine Comirnaty marginally increases the risk of heart inflammation, although the risk is higher among those who contract SARS-CoV-2 infection, as reported in Yahoo!